The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
DNA hypermethylation biomarkers to predict therapy response of antiangiogenic therapy in metastatic renal cell carcinoma patients.
Inga Peters
No relevant relationships to disclose
Natalia Dubrowinskaja
No relevant relationships to disclose
Mahmoud Abbas
No relevant relationships to disclose
Christoph Seidel
No relevant relationships to disclose
Michael Kogosov
No relevant relationships to disclose
Ralph Scherer
No relevant relationships to disclose
Kai Gebauer
No relevant relationships to disclose
Axel S. Merseburger
No relevant relationships to disclose
Markus A. Kuczyk
No relevant relationships to disclose
Viktor Gruenwald
No relevant relationships to disclose
Juergen Serth
No relevant relationships to disclose